EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Edwards Lifesciences

05/11/2022 | 07:17am EDT


© MT Newswires 2022
All news about EDWARDS LIFESCIENCES CORPORATION
06/15INSIDER SELL : Edwards Lifesciences
MT
06/09Corvia Medical, Inc. announced that it has received $54 million in funding from Accelme..
CI
06/09Corvia Medical, Inc. announced that it has received $54 million funding from General Ca..
CI
06/02TRANSCRIPT : Edwards Lifesciences Corporation Presents at Bernstein 38th Annual Strategic ..
CI
05/23Edwards lifesciences to present at the bernstein 38th annual strategic decisions confer..
PR
05/19Opsens Presents Results of First-in-human Study of SavvyWire at European Conf
MT
05/17Citigroup Adjusts Price Target on Edwards Lifesciences to $115 From $134, Reiterates Bu..
MT
05/16Edwards announces key events for europcr 2022
PR
05/11INSIDER SELL : Edwards Lifesciences
MT
05/04EDWARDS LIFESCIENCES CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
More recommendations
Financials (USD)
Sales 2022 5 737 M - -
Net income 2022 1 573 M - -
Net cash 2022 1 336 M - -
P/E ratio 2022 39,0x
Yield 2022 -
Capitalization 60 552 M 60 552 M -
EV / Sales 2022 10,3x
EV / Sales 2023 9,05x
Nbr of Employees 15 700
Free-Float 95,9%
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 97,39 $
Average target price 124,33 $
Spread / Average Target 27,7%
EPS Revisions
Managers and Directors
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
Nicholas J. Valeriani Independent Director
Kieran Thomas Gallahue Independent Director
Sector and Competitors